SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

ブレインコンピュータインターフェース市場 : 2029年までの世界予測

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2024年5月

Brain-Computer Interface Market – Global Forecast to 2029

ブレインコンピュータインターフェース市場 : 製品（非侵襲的、侵襲的、部分侵襲的）、テクノロジー（EEG、MEG、ECoG、fMRI）、用途（障害/リハビリテーション、支援技術、メンタルヘルス、研究）、エンドユーザー – 2029年までの世界予測
Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User – Global Forecast to 2029

ページ数242
図表数274
価格
シングルユーザライセンスUSD 4,950
マルチユーザライセンス（5名）USD 6,650
コーポレートライセンスUSD 8,150
エンタープライズサイトライセンスUSD 10,000
種別英文調査報告書

お問合せ・ご注文　　出版社・価格・納期について

Report Overview

The brain computer interface market is projected to reach USD 506 million by 2029 from USD 262 million in 2024, at a CAGR 14.1% during the forecast period.
ブレインコンピュータインターフェース市場は、予測期間中のCAGR 14.1%で、2024年の2億6,200万米ドルから2029年までに5億600万米ドルに達すると予測されています
ブレインコンピュータインターフェース市場 : 2029年までの世界予測
The growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable BCI devices, and rising investments in research and development, along with the increasing demand for non-invasive and wearable BCI devices are the factors that will drive the growth of this market. On the other hand, stringent regulatory requirements and high cost associated BCI systems may impede the adoption of brain computer interface solutions to a certain extent over the forecast period.

“Hardware segment is expected to register highest growth in the forecast period, by component.”

Based on component, the brain computer interface market is segmented into hardware and software. The hardware segment is projected to witness the highest growth rate during the forecast period. Growth in this market can be attributed to the growing focus on adopting wearable BCI products such as headsets, headphones and others in response to the significant investment in hardware development by companies and research institutions.
ブレインコンピュータインターフェース市場 : 2029年までの世界予測 ecosystem

“Non-invasive brain computer interface segment is expected to register highest growth in the forecast period of brain computer interface market, by product type.”

Based on product type, the brain computer interface market is segmented into non-invasive brain computer interface, partially invasive brain computer interface, and invasive brain computer interface. The non-invasive brain computer interface segment is projected to witness the highest growth rate during the forecast period. This segment is expected to witness significant growth due to eliminating the need for surgical implantation, and growing adoption of this segment among end users.

“The electroencephalography (EEG) segment is expected to register highest growth in the forecast period, by end user.”

Based on technology, the brain computer interface market is segmented into Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Magnetoencephalography (MEG), Electrocorticography (ECoG), and Functional Near-Infrared Spectroscopy (fNIRS). The electroencephalography (EEG) segment is projected to witness the highest growth rate during the forecast period. The adoption of EEG is expected to increase due to the large number of players involved in developing EEG hardware, and growing EEG based neuroscience research.

“The disabilities restoration/ rehabilitation accounted for the largest share of the application segment of the brain computer interface market”

Based on application, the brain computer interface market is segmented into disabilities restoration/ rehabilitation, assistive technologies, and other applications.  The increasing prevalence of neurological  conditions  like  stroke,  spinal  cord  injury,  and  amyotrophic lateral sclerosis (ALS) along with the growing healthcare spending and rising research and development initiatives is expected to fuel the demand for disabilities restoration/ rehabilitation solutions among end users.

“The rehabilitation centers segment is expected to register highest growth in the forecast period, by end user.”

Based on end user, the brain computer interface market is segmented into hospitals & clinics, rehabilitation centers, homecare settings, and other end users. . The rehabilitation centers segment is projected to witness the highest growth rate during the forecast period. The growth of brain computer interface adoption among rehabilitation centers is driven by their commitment to leveraging technological advancements, lower costs, easy accessibility, and lower waiting times as compared to hospitals to improve patient outcomes.

“Asia Pacific to register the highest growth in the brain computer interface market in the forecast period.”

The global brain computer interface market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and Middle East & Africa. In 2023, Asia Pacific was expected to register the highest growth for brain computer interface solutions in the forecast period. Factors such as the affordable labor and a skilled workforce, rising disposable incomes, increasing incidence of neurodegenerative disorders, and a growing governmental focus on healthcare reforms within the region are expected to drive the growth of the brain computer interface market in the Asia Pacific.
Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:
  •  By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
  • By Designation: C-level Executives (27%), Director-level (18%), and Others (55%)
  • By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East and Africa (5%)

ブレインコンピュータインターフェース市場 : 2029年までの世界予測 region

The prominent players in this market are Advanced Brain Monitoring, Inc. (US), Neurosky (US), Brain Products GmbH (Germany), CGX (US), Ripple Neuro (US), Neurable (US), InteraXon (US), Open BCI (US), Neurolutions, Inc. (US), ANT Neuro (Netherlands), Bitbrain (Spain), Kernel (US), Paradromics (US), BrainCo (US), Blackrock Neurotech (US), G.Tech Medical Engineering GmbH (Austria), Emotiv (US), BirgerMind (Latvia), Cognixion (US), Artinis Medical Systems (Netherlands), MindMaze (Switzerland), Cortec GmbH (Germany), AAVAA Inc. (Canada), Nexstem (India), and Conscious Labs (France). Players adopted organic as well as inorganic growth strategies such as new product launches, agreements, collaborations, and expansions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the brain computer interface market based on component, product type, technology, application, end user, and region.  The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total brain computer interface market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

Analysis of key drivers (growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable BCI devices, rising investments in research and development), restraints (high cost of BCI devices, and stringent regulatory requirements), opportunities (growth opportunities in emerging markets, and growing applications of BCI technology) and challenge (shortage of trained medical professionals, and data security and privacy concerns)
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the brain computer interface market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of brain computer interface solutions across regions.
  • Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the brain computer interface market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the brain computer interface market.

Table of Contents

1            INTRODUCTION            34

1.1         STUDY OBJECTIVES      34

1.2         MARKET DEFINITION   34

1.2.1      INCLUSIONS & EXCLUSIONS     34

1.3         MARKET SCOPE             35

1.3.1      MARKETS COVERED     35

FIGURE 1           BRAIN-COMPUTER INTERFACE MARKET SEGMENTATION              35

1.3.2      REGIONS COVERED      35

FIGURE 2           BRAIN-COMPUTER INTERFACE MARKET: REGIONAL SEGMENTATION           35

1.3.3      YEARS CONSIDERED     36

1.3.4      CURRENCY CONSIDERED          36

1.4         STAKEHOLDERS            36

1.5         RECESSION IMPACT: BRAIN-COMPUTER INTERFACE MARKET  37

2            RESEARCH METHODOLOGY     38

2.1         RESEARCH DATA           38

2.2         RESEARCH APPROACH 38

FIGURE 3           RESEARCH APPROACH 38

2.2.1      SECONDARY DATA       38

2.2.1.1   Key data from secondary sources     39

2.2.2      PRIMARY DATA 40

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    41

FIGURE 5           PRIMARY SOURCES       41

2.2.2.1   Key data from primary sources         42

2.3         MARKET SIZE ESTIMATION METHODOLOGY    42

FIGURE 6           MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS              43

FIGURE 7           TOP-DOWN APPROACH             43

FIGURE 8           BOTTOM-UP APPROACH           44

FIGURE 9           CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN-COMPUTER INTERFACE MARKET (2024–2029)           45

FIGURE 10         CAGR PROJECTIONS     45

2.4         MARKET DATA ESTIMATION AND TRIANGULATION     46

FIGURE 11         DATA TRIANGULATION METHODOLOGY         46

2.5         ASSUMPTIONS FOR THE STUDY             47

2.6         LIMITATIONS   47

2.6.1      METHODOLOGY-RELATED LIMITATIONS         47

2.6.2      SCOPE-RELATED LIMITATIONS             47

2.7         RISK ASSESSMENT         48

TABLE 1             RISK ASSESSMENT: BRAIN-COMPUTER INTERFACE MARKET              48

2.8         RECESSION IMPACT ANALYSIS 48

3            EXECUTIVE SUMMARY 49

FIGURE 12         BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)     49

FIGURE 13         BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)     50

FIGURE 14         BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2024 VS. 2027 (USD MILLION)     50

FIGURE 15         BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2024 VS. 2027 (USD MILLION)     51

FIGURE 16         BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2024 VS. 2027 (USD MILLION)             52

FIGURE 17         GEOGRAPHICAL SNAPSHOT OF BRAIN-COMPUTER INTERFACE MARKET    53

4            PREMIUM INSIGHTS      54

4.1         BRAIN-COMPUTER INTERFACE MARKET OVERVIEW     54

FIGURE 18         GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH          54

4.2         ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE AND COUNTRY (2023)      55

FIGURE 19         NON-INVASIVE BCI ACCOUNTED FOR LARGEST MARKET SHARE IN 2023  55

4.3         BRAIN-COMPUTER INTERFACE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           56

FIGURE 20         CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       56

4.4         BRAIN-COMPUTER INTERFACE MARKET, BY REGION 2023−2029              57

FIGURE 21         NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD              57

4.5         BRAIN-COMPUTER INTERFACE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES            57

FIGURE 22         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD       57

5            MARKET OVERVIEW     58

5.1         INTRODUCTION            58

5.2         MARKET DYNAMICS     58

FIGURE 23         BRAIN-COMPUTER INTERFACE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       58

5.2.1      DRIVERS            59

5.2.1.1   Growing incidence & prevalence of neurological disorders         59

5.2.1.2   Increasing demand for non-invasive & wearable BCI devices     59

5.2.1.3   Rising investment in R&D 60

5.2.2      RESTRAINTS     60

5.2.2.1   High cost of BCI systems   60

5.2.3      OPPORTUNITIES           61

5.2.3.1   Growth opportunities in emerging economies 61

FIGURE 24         GLOBAL HEALTHCARE EXPENDITURE SHARE, 1995 VS 2022              61

5.2.3.2   Growing applications of BCI technology        62

5.2.4      CHALLENGES   62

5.2.4.1   Shortage of trained medical professionals      62

5.2.4.2   Data security & privacy concerns     62

5.3         INDUSTRY TRENDS       63

5.3.1      FOCUS ON NON-INVASIVE BCIS              63

5.3.2      INTEGRATION WITH WEARABLE TECHNOLOGY            63

5.4         PRICING ANALYSIS        63

5.4.1      AVERAGE SELLING PRICE TREND, BY HARDWARE         63

TABLE 2             AVERAGE SELLING PRICE OF BRAIN-COMPUTER INTERFACE, BY HARDWARE 63

5.4.2      AVERAGE SELLING PRICE TREND OF BRAIN-COMPUTER INTERFACE, BY PRODUCT TYPE       64

TABLE 3             AVERAGE SELLING PRICE OF BRAIN-COMPUTER INTERFACE, BY PRODUCT TYPE       64

5.5         VALUE CHAIN ANALYSIS            64

FIGURE 25         VALUE CHAIN ANALYSIS: BRAIN-COMPUTER INTERFACE MARKET            64

5.6         ECOSYSTEM ANALYSIS 65

FIGURE 26         ECOSYSTEM ANALYSIS: KEY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET    65

5.7         PORTER’S FIVE FORCES ANALYSIS         65

TABLE 4             BRAIN-COMPUTER INTERFACE MARKET: PORTER’S FIVE FORCES             65

5.7.1      BARGAINING POWER OF BUYERS           66

5.7.2      BARGAINING POWER OF SUPPLIERS     66

5.7.3      THREAT OF NEW ENTRANTS    66

5.7.4      THREAT OF SUBSTITUTES         66

5.7.5      INTENSITY OF COMPETITIVE RIVALRY 67

5.8         KEY STAKEHOLDERS & BUYING CRITERIA          67

5.8.1      KEY STAKEHOLDERS IN BUYING PROCESS         67

TABLE 5             LIST OF KEY STAKEHOLDERS AND THEIR ROLE             67

TABLE 6             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY COMPONENT   68

5.8.2      BUYING CRITERIA         68

FIGURE 27         KEY BUYING CRITERIA FOR BRAIN-COMPUTER INTERFACE, BY COMPONENT   68

TABLE 7             KEY BUYING CRITERIA FOR BRAIN-COMPUTER INTERFACE, BY COMPONENT   68

5.9         REGULATORY LANDSCAPE       69

5.9.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          69

TABLE 8             NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         69

TABLE 9             EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69

TABLE 10           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         69

5.9.2      REGULATORY ANALYSIS            70

5.9.2.1   North America     70

5.9.2.1.1 US         70

TABLE 11           US FDA: CLASSIFICATION OF MEDICAL DEVICES           70

TABLE 12           US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              71

5.9.2.2   Europe  71

5.9.2.3   Asia Pacific          72

5.9.2.3.1 China     72

TABLE 13           CHINA: CLASSIFICATION OF MEDICAL DEVICES             72

5.9.2.3.2 India      72

TABLE 14           INDIA: CLASSIFICATION OF NON-NOTIFIED MEDICAL DEVICES            73

5.9.2.4   Latin America      73

5.9.2.4.1 Brazil     73

5.9.2.5   Middle East & Africa          73

5.9.2.5.1 UAE      73

5.10       TECHNOLOGY ANALYSIS           74

5.10.1    KEY TECHNOLOGIES    74

5.10.1.1 Artificial Intelligence (AI) and Machine Learning (ML)            74

5.10.1.2 Signal Processing 74

5.10.2    COMPLEMENTARY TECHNOLOGIES     75

5.10.2.1 Neuroimaging      75

5.10.2.2 Wearable Technology        76

5.10.3    ADJACENT TECHNOLOGIES      76

5.10.3.1 Robotics & Prosthetics       76

5.10.3.2 Virtual Reality (VR) & Augmented Reality (AR)          77

5.11       PATENT ANALYSIS        77

5.11.1    PATENT PUBLICATION TRENDS            77

5.11.2    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN-COMPUTER INTERFACE             78

FIGURE 28         JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN-COMPUTER INTERFACE PATENTS, 2013–2023     78

TABLE 15           NUMBER OF DOCUMENTS FOR BRAIN-COMPUTER INTERFACE PATENTS, 2013–2023            78

5.11.3    PATENT APPLICATIONS AND OWNERS 79

FIGURE 29         MAJOR PATENTS FOR BRAIN-COMPUTER INTERFACE (2013–2023)    79

5.11.4    LIST OF PATENTS/PATENT APPLICATIONS       80

TABLE 16           LIST OF PATENTS/PATENT APPLICATIONS IN BRIAN COMPUTER INTERFACE MARKET, JANUARY 2021-MAY 2024       80

5.12       REIMBURSEMENT SCENARIO ANALYSIS             82

5.13       BUSINESS MODEL ANALYSIS     82

5.14       TRADE ANALYSIS          83

5.14.1    TRADE ANALYSIS FOR BRAIN-COMPUTER INTERFACE MARKET              83

FIGURE 30         IMPORT DATA FOR BRAIN-COMPUTER INTERFACE MARKET (HS CODE 852692), BY COUNTRY, 2021–2023 (USD THOUSAND) 83

FIGURE 31         EXPORT DATA FOR BRAIN-COMPUTER INTERFACE MARKET (HS CODE 852692), BY COUNTRY, 2021–2023 (USD THOUSAND) 84

5.15       CASE STUDY ANALYSIS 84

TABLE 17           CASE STUDY 1: EXPLORING USER-CENTERED DESIGN PERSPECTIVES IN BRAIN-COMPUTER INTERFACE RESEARCH   84

TABLE 18           CASE STUDY 2: ASSESSING THE INTEGRATION OF BRAIN-COMPUTER INTERFACE AND INTERNET OF THINGS FOR HEALTHCARE APPLICATIONS 85

5.16       KEY CONFERENCES & EVENTS, 2024–2025           85

TABLE 19           LIST OF KEY CONFERENCES & EVENTS IN BRAIN-COMPUTER INTERFACE MARKET, JANUARY 2024–DECEMBER 2025   85

5.17       UNMET NEEDS AND END-USER EXPECTATIONS             86

5.17.1    UNMET NEEDS 86

TABLE 20           UNMET NEEDS IN BRAIN-COMPUTER INTERFACE MARKET              86

5.17.2    END-USER EXPECTATIONS       87

TABLE 21           END-USER EXPECTATIONS IN BRAIN-COMPUTER INTERFACE MARKET            87

5.18       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 88

5.19       INVESTMENT AND FUNDING LANDSCAPE         89

FIGURE 32         FUNDING IN BRAIN-COMPUTER INTERFACE MARKET, BY PLAYER 89

6            BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT       90

6.1         INTRODUCTION            91

TABLE 22           BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          91

6.2         HARDWARE      91

6.2.1      ADVANCEMENTS IN HARDWARE AND INCREASING DEMAND FOR NON-INVASIVE BCI SOLUTIONS TO DRIVE MARKET GROWTH  91

TABLE 23           BRAIN-COMPUTER INTERFACE HARDWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    92

6.3         SOFTWARE       92

6.3.1      INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED BCI SOFTWARE SOLUTIONS TO FUEL MARKET GROWTH    92

TABLE 24           BRAIN-COMPUTER INTERFACE SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    93

7            BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE   94

7.1         INTRODUCTION            95

TABLE 25           BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)          95

7.2         NON-INVASIVE BRAIN-COMPUTER INTERFACES            95

7.2.1      DEVELOPMENT OF ADVANCED EEG HEADSETS TO DRIVE ADOPTION              95

TABLE 26           NON-INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    96

7.3         PARTIALLY INVASIVE BRAIN-COMPUTER INTERFACES 96

7.3.1      TECHNOLOGICAL ADVANCEMENTS AND RISING NEUROLOGICAL DISORDER INCIDENCE TO DRIVE DEMAND       96

TABLE 27          PARTIALLY INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            97

7.4         INVASIVE BRAIN-COMPUTER INTERFACES        98

7.4.1      GROWING R&D AND RISING INVESTMENTS TO FUEL MARKET GROWTH          98

TABLE 28           INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    99

8            BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY      100

8.1         INTRODUCTION            101

TABLE 29           BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          101

8.2         ELECTROENCEPHALOGRAPHY 101

8.2.1      TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET GROWTH              101

TABLE 30           EEG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    102

8.3         MAGNETOENCEPHALOGRAPHY            103

8.3.1      HIGH COST OF MEG-BASED BCI SOLUTIONS TO LIMIT MARKET GROWTH          103

TABLE 31           MEG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    104

8.4         ELECTROCORTICOGRAPHY      104

8.4.1      FOCUS ON ESTABLISHING FEASIBILITY & EFFICACY OF ECOG-BASED BCIS TO DRIVE MARKET            104

TABLE 32           ECOG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    105

8.5         FUNCTIONAL MAGNETIC RESONANCE IMAGING           105

8.5.1      LARGE SIZE AND HIGH PRICE OF FMRI SCANNERS TO LIMIT APPLICATIONS IN HOME CARE SETTINGS         105

TABLE 33           FMRI-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    106

8.6         FUNCTIONAL NEAR-INFRARED SPECTROSCOPY            106

8.6.1      PORTABILITY, SAFETY, AND REAL-TIME BRAIN ACTIVITY MONITORING TO FUEL DEMAND          106

TABLE 34           FNIRS-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    107

8.7         DIRECT DATA INTERFACE         107

8.7.1      HIGH COST AND LIMITED REIMBURSEMENT OPTIONS TO RESTRAIN GROWTH          107

TABLE 35           DDI-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    108

9            BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION       109

9.1         INTRODUCTION            110

TABLE 36           BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          110

9.2         ASSISTIVE TECHNOLOGIES       110

9.2.1      DEVELOPMENT OF INNOVATIVE SOLUTIONS AND GROWING R&D TO BOOST ADOPTION OF BCI IN ASSISTIVE TECHNOLOGIES          110

TABLE 37           BRAIN-COMPUTER INTERFACE MARKET FOR ASSISTIVE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)         111

9.3         DISABILITIES & REHABILITATION         112

9.3.1      RISING DEMAND FOR ADVANCED SOLUTIONS AND INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET        112

TABLE 38           BRAIN-COMPUTER INTERFACE MARKET FOR DISABILITIES & REHABILITATION, BY COUNTRY, 2022–2029 (USD MILLION)      113

9.4         OTHER APPLICATIONS 113

TABLE 39           BRAIN-COMPUTER INTERFACE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           114

10          BRAIN-COMPUTER INTERFACE MARKET, BY END USER 115

10.1       INTRODUCTION            116

TABLE 40           BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)     116

10.2       HOSPITALS & CLINICS  116

10.2.1    EARLY ADOPTION, WIDE APPLICATIONS, AND GROWING R&D TO SUPPORT MARKET GROWTH    116

TABLE 41           BRAIN-COMPUTER INTERFACE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)         118

10.3       REHABILITATION CENTERS      118

10.3.1    SHORTAGE OF TRAINED PROFESSIONALS TO CHALLENGE MARKET GROWTH          118

TABLE 42           BRAIN-COMPUTER INTERFACE MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)   120

10.4       HOME CARE SETTINGS 120

10.4.1    PREFERENCE FOR IN-HOME CARE AND GROWING AGING POPULATION TO DRIVE DEMAND        120

TABLE 43           BRAIN-COMPUTER INTERFACE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)      121

10.5       OTHER END USERS        121

TABLE 44           BRAIN-COMPUTER INTERFACE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)             122

11          BRAIN-COMPUTER INTERFACE MARKET, BY REGION    123

11.1       INTRODUCTION            124

TABLE 45           BRAIN-COMPUTER INTERFACE MARKET, BY REGION, 2022–2029 (USD MILLION)     124

11.2       NORTH AMERICA          124

11.2.1    NORTH AMERICA: RECESSION IMPACT 124

FIGURE 33         NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET SNAPSHOT        125

TABLE 46           NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            126

TABLE 47           NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)      126

TABLE 48           NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)  126

TABLE 49           NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    127

TABLE 50           NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     127

TABLE 51           NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)            128

11.2.2    US         128

11.2.2.1 US to dominate North American market        128

TABLE 52           US: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          129

TABLE 53           US: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)             130

TABLE 54           US: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          130

TABLE 55          US: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          130

TABLE 56           US: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          131

11.2.3    CANADA            131

11.2.3.1 Growing adoption and government support to propel market growth       131

TABLE 57           CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           132

TABLE 58           CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       132

TABLE 59           CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          133

TABLE 60           CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           133

TABLE 61           CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)             134

11.3       EUROPE             134

11.3.1    EUROPE: RECESSION IMPACT   134

TABLE 62           EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    135

TABLE 63           EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           135

TABLE 64           EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       135

TABLE 65           EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          136

TABLE 66           EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           136

TABLE 67           EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)             137

11.3.2    GERMANY         137

11.3.2.1 Government support and demand for neurorehabilitation solutions to fuel market growth   137

TABLE 68           GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           138

TABLE 69           GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       138

TABLE 70           GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          139

TABLE 71           GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           139

TABLE 72           GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)             140

11.3.3    UK         140

11.3.3.1 Rising prevalence of neurological disorders to drive market        140

TABLE 73          UK: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)          141

TABLE 74           UK: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)             141

TABLE 75           UK: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          141

TABLE 76           UK: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           142

TABLE 77           UK: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          142

11.3.4    FRANCE             142

11.3.4.1 Rising geriatric population to increase demand for BCI solutions             142

TABLE 78           FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           143

TABLE 79           FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       143

TABLE 80           FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          144

TABLE 81           FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           144

TABLE 82           FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)             145

11.3.5    ITALY   145

11.3.5.1 Increasing initiatives to propel market growth              145

TABLE 83           ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           146

TABLE 84           ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)             146

TABLE 85           ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          146

TABLE 86           ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           147

TABLE 87           ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          147

11.3.6    SPAIN   147

11.3.6.1 Rising R&D and improving health spending to drive market      147

TABLE 88           SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           148

TABLE 89           SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)             148

TABLE 90           SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          149

TABLE 91           SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           149

TABLE 92           SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          150

11.3.7    REST OF EUROPE           150

TABLE 93           REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           150

TABLE 94           REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       151

TABLE 95           REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          151

TABLE 96           REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           151

TABLE 97           REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)    152

11.4       ASIA PACIFIC    152

11.4.1    ASIA PACIFIC: RECESSION IMPACT        152

FIGURE 34         ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET SNAPSHOT        153

TABLE 98           ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    154

TABLE 99           ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           154

TABLE 100         ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       154

TABLE 101         ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          155

TABLE 102         ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           155

TABLE 103         ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)    156

11.4.2    JAPAN  156

11.4.2.1 Growing demand for assistive technologies to fuel market growth            156

TABLE 104         JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           157

TABLE 105         JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)             157

TABLE 106         JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          158

TABLE 107         JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           158

TABLE 108        JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          159

11.4.3    CHINA  159

11.4.3.1 Technological innovations to increase demand             159

TABLE 109         CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           160

TABLE 110         CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       160

TABLE 111         CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          161

TABLE 112         CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           161

TABLE 113        CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          162

11.4.4    INDIA   162

11.4.4.1 Increasing government initiatives to boost demand for BCI        162

TABLE 114         INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           163

TABLE 115         INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)             163

TABLE 116         INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          163

TABLE 117         INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           164

TABLE 118         INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)          164

11.4.5    REST OF ASIA PACIFIC  164

TABLE 119         REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  165

TABLE 120         REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)            165

TABLE 121         REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 165

TABLE 122         REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  166

TABLE 123         REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)         166

11.5       LATIN AMERICA             167

11.5.1    LATIN AMERICA: RECESSION IMPACT   167

TABLE 124         LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    167

TABLE 125         LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           168

TABLE 126         LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       168

TABLE 127         LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          168

TABLE 128         LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           169

TABLE 129         LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)    169

11.5.2    BRAZIL 169

11.5.2.1 High cost of BCI solutions to hamper market growth   169

TABLE 130         BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           170

TABLE 131         BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       170

TABLE 132         BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          171

TABLE 133         BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           171

TABLE 134         BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)             172

11.5.3    MEXICO             172

11.5.3.1 Initiatives for healthcare infrastructure development to support market growth              172

TABLE 135         MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           172

TABLE 136         MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       173

TABLE 137         MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          173

TABLE 138         MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           173

TABLE 139         MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)             174

11.5.4    REST OF LATIN AMERICA          174

TABLE 140         REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  174

TABLE 141         REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)            175

TABLE 142         REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 175

TABLE 143         REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  175

TABLE 144         REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)         176

11.6       MIDDLE EAST & AFRICA             176

11.6.1    MIDDLE EAST & AFRICA: RECESSION IMPACT   176

TABLE 145         MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY REGION, 2022–2029 (USD MILLION)            177

TABLE 146         MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)  177

TABLE 147         MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)            177

TABLE 148         MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 178

TABLE 149         MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  178

TABLE 150         MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)         179

11.6.2    GCC COUNTRIES           179

11.6.2.1 Healthcare infrastructural development to drive demand for BCI solutions              179

TABLE 151         GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)           179

TABLE 152         GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)       180

TABLE 153         GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          180

TABLE 154         GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           180

TABLE 155         GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION)    181

11.6.3    REST OF MIDDLE EAST & AFRICA           181

TABLE 156         REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022–2029 (USD MILLION)         181

TABLE 157         REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022–2029 (USD MILLION)     182

TABLE 158         REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)       182

TABLE 159         REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)        182

TABLE 160         REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022–2029 (USD MILLION) 183

12          COMPETITIVE LANDSCAPE       184

12.1       OVERVIEW        184

12.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          184

12.2.1    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET          185

FIGURE 35         OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES             185

12.3       MARKET SHARE ANALYSIS         186

FIGURE 36         MARKET SHARE ANALYSIS OF KEY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET (2023)             186

TABLE 161         BRAIN-COMPUTER INTERFACE MARKET: DEGREE OF COMPETITION 186

12.4       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   187

12.4.1    STARS  187

12.4.2    PERVASIVE PLAYERS     188

12.4.3    EMERGING LEADERS    188

12.4.4    PARTICIPANTS 188

FIGURE 37         BRAIN-COMPUTER INTERFACE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023      189

12.4.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      190

12.4.5.1 Company footprint            190

FIGURE 38         BRAIN-COMPUTER INTERFACE MARKET: COMPANY FOOTPRINT      190

12.4.5.2 Component footprint         190

TABLE 162         BRAIN-COMPUTER INTERFACE MARKET: COMPONENT FOOTPRINT      190

12.4.5.3 Product type footprint       191

TABLE 163         BRAIN-COMPUTER INTERFACE MARKET: PRODUCT TYPE FOOTPRINT      191

12.4.5.4 Technology footprint         192

TABLE 164         BRAIN-COMPUTER INTERFACE MARKET: TECHNOLOGY FOOTPRINT      192

12.4.5.5 Application footprint         192

TABLE 165         BRAIN-COMPUTER INTERFACE MARKET: APPLICATION FOOTPRINT      192

12.5       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          193

12.5.1    PROGRESSIVE COMPANIES       193

12.5.2    DYNAMIC COMPANIES 193

12.5.3    STARTING BLOCKS       193

12.5.4    RESPONSIVE COMPANIES          193

FIGURE 39         BRAIN-COMPUTER INTERFACE MARKET: COMPANY EVALUATION MATRIX (SMES/ STARTUPS), 2023             194

12.5.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             195

TABLE 166         BRAIN-COMPUTER INTERFACE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS    195

TABLE 167         BRAIN-COMPUTER INTERFACE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS        195

12.6       VALUATION AND FINANCIAL METRICS 196

FIGURE 40         EV/EBITDA OF KEY VENDORS   196

FIGURE 41         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 196

12.7       BRAND/PRODUCT COMPARISON          197

FIGURE 42         BRAIN-COMPUTER INTERFACE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS          197

12.8       COMPETITIVE SCENARIO          198

12.8.1    PRODUCT LAUNCHES & APPROVALS    198

TABLE 168         BRAIN-COMPUTER INTERFACE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024      198

12.8.2    DEALS  198

TABLE 169         BRAIN-COMPUTER INTERFACE MARKET: DEALS, JANUARY 2021–MAY 2024 198

12.8.3    EXPANSIONS    199

TABLE 170         BRAIN-COMPUTER INTERFACE MARKET: EXPANSIONS, JANUARY 2021–MAY 2024            199

13          COMPANY PROFILES    200

13.1       KEY PLAYERS   200

(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*

13.1.1    NEUROSKY        200

TABLE 171         NEUROSKY: COMPANY OVERVIEW        200

TABLE 172         NEUROSKY: PRODUCTS OFFERED         200

13.1.2    EMOTIV             202

TABLE 173         EMOTIV: COMPANY OVERVIEW             202

TABLE 174         EMOTIV: PRODUCTS OFFERED 202

13.1.3    ANT NEURO      204

TABLE 175         ANT NEURO: COMPANY OVERVIEW      204

TABLE 176         ANT NEURO: PRODUCTS OFFERED       204

TABLE 177         ANT NEURO: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021–MAY 2024) 205

TABLE 178         ANT NEURO: EXPANSIONS (JANUARY 2021–MAY 2024)   205

13.1.4    G.TEC MEDICAL ENGINEERING GMBH 207

TABLE 179         G.TEC MEDICAL ENGINEERING GMBH: COMPANY OVERVIEW              207

TABLE 180         G.TEC MEDICAL ENGINEERING GMBH: PRODUCTS OFFERED              207

13.1.5    NEURABLE        210

TABLE 181         NEURABLE: COMPANY OVERVIEW         210

TABLE 182         NEURABLE: PRODUCTS OFFERED         210

TABLE 183         NEURABLE: DEALS (JANUARY 2021–MAY 2024)   211

13.1.6    ADVANCED BRAIN MONITORING, INC. 212

TABLE 184         ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW              212

TABLE 185         ADVANCED BRAIN MONITORING, INC.: PRODUCTS OFFERED              212

13.1.7    BRAIN PRODUCTS GMBH           214

TABLE 186         BRAIN PRODUCTS GMBH: COMPANY OVERVIEW           214

TABLE 187         BRAIN PRODUCTS GMBH: PRODUCTS OFFERED            214

13.1.8    CGX      216

TABLE 188         CGX: COMPANY OVERVIEW      216

TABLE 189         CGX: PRODUCTS OFFERED       216

TABLE 190         CGX: EXPANSIONS (JANUARY 2021–MAY 2024)   217

13.1.9    RIPPLE NEURO 218

TABLE 191         RIPPLE NEURO: COMPANY OVERVIEW 218

TABLE 192         RIPPLE NEURO: PRODUCTS OFFERED  218

13.1.10  BITBRAIN TECHNOLOGIES       219

TABLE 193         BITBRAIN TECHNOLOGIES: COMPANY OVERVIEW        219

TABLE 194         BITBRAIN TECHNOLOGIES: PRODUCTS OFFERED         219

13.1.11  OPEN BCI           221

TABLE 195         OPENBCI: COMPANY OVERVIEW            221

TABLE 196         OPENBCI: PRODUCTS OFFERED             221

13.1.12  ARTINIS MEDICAL SYSTEMS      223

TABLE 197         ARTINIS MEDICAL SYSTEMS: COMPANY OVERVIEW      223

TABLE 198         ARTINIS MEDICAL SYSTEMS: PRODUCTS OFFERED       223

13.1.13  PARADROMICS 225

TABLE 199         PARADROMICS: COMPANY OVERVIEW 225

TABLE 200         PARADROMICS: PRODUCTS OFFERED  225

TABLE 201         PARADROMICS: PRODUCT APPROVALS (JANUARY 2021–MAY 2024)    226

13.1.14  BRAINCO, INC.  227

TABLE 202         BRAINCO, INC.: COMPANY OVERVIEW  227

TABLE 203         BRAINCO, INC.: PRODUCTS OFFERED   227

13.1.15  MINDMAZE       228

TABLE 204         MINDMAZE: COMPANY OVERVIEW       228

TABLE 205         MINDMAZE: PRODUCTS OFFERED        228

TABLE 206         MINDMAZE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021–MAY 2024) 228

TABLE 207         MINDMAZE: DEALS (JANUARY 2021–MAY 2024) 229

13.1.16  COGNIXION      230

TABLE 208         COGNIXION: COMPANY OVERVIEW      230

TABLE 209         COGNIXION: PRODUCTS OFFERED       230

TABLE 210         COGNIXION: PRODUCT APPROVALS (JANUARY 2021–MAY 2024)    231

13.1.17  BLACKROCK NEUROTECH        232

TABLE 211         BLACKROCK NEUROTECH: COMPANY OVERVIEW         232

TABLE 212         BLACKROCK NEUROTECH: PRODUCTS OFFERED          232

TABLE 213         BLACKROCK NEUROTECH: PRODUCT LAUNCHES (JANUARY 2021–MAY 2024) 232

13.1.18  CORTEC GMBH 233

TABLE 214         CORTEC GMBH: COMPANY OVERVIEW 233

TABLE 215         CORTEC GMBH: PRODUCTS OFFERED 233

13.1.19  INTERAXON, INC.           234

TABLE 216         INTERAXON, INC.: COMPANY OVERVIEW           234

TABLE 217         INTERAXON, INC.: PRODUCTS OFFERED            234

13.1.20  NEUROLUTIONS, INC.   235

TABLE 218         NEUROLUTIONS, INC.: COMPANY OVERVIEW   235

TABLE 219         NEUROLUTIONS, INC.: PRODUCTS OFFERED    235

TABLE 220         NEUROLUTIONS: PRODUCT APPROVALS (JANUARY 2021–MAY 2024)    235

13.2       OTHER PLAYERS           236

13.2.1    CONSCIOUS LABS          236

TABLE 221         CONSCIOUS LABS: COMPANY OVERVIEW          236

TABLE 222         CONSCIOUS LABS: PRODUCTS OFFERED           236

13.2.2    KERNEL             237

TABLE 223         KERNEL: COMPANY OVERVIEW 237

TABLE 224         KERNEL: PRODUCTS OFFERED 237

TABLE 225         KERNEL: PRODUCT LAUNCHES (JANUARY 2021–MAY 2024)              238

13.2.3    AAVAA INC.       239

TABLE 226         AAVAA INC.: COMPANY OVERVIEW       239

TABLE 227         AAVAA INC.: PRODUCTS OFFERED        239

TABLE 228         AAVAA: PRODUCT LAUNCHES (JANUARY 2021–MAY 2024)              240

13.2.4    NEXSTEM          241

TABLE 229         NEXSTEM: COMPANY OVERVIEW           241

TABLE 230         NEXSTEM: PRODUCTS OFFERED            241

13.2.5    BIRGERMIND    242

TABLE 231         BIRGERMIND: COMPANY OVERVIEW    242

TABLE 232         BIRGERMIND: PRODUCTS OFFERED     242

*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

14          APPENDIX         243

14.1       DISCUSSION GUIDE      243

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             247

14.3       CUSTOMIZATION OPTIONS      249

14.4       RELATED REPORTS       249

14.5       AUTHOR DETAILS         250

医療・医薬の最新記事8件